Our website detected that you are using a browser (Internet Explorer) that we no longer support. Please use the following browsers instead: Chrome, Firefox, Edge, or Safari.
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
Updates regarding government operating status and resumption of normal operations can be found at opm .gov.
This repository is under review for potential modification in compliance with Administration directives.
First, a researcher meets with a participant, performs a clinical assessment, and obtains biospecimens. Participants include people with Parkinson's Disease, people without Parkinson's Disease (controls), and people with a Parkinson-like disorder (Parkinsonism).
After meeting with a patient, the researcher submits biosamples to the NINDS biorepository, and de-identified clinical data to the PDBP Data Management Resource (DMR).
Once data is in the PDBP DMR, qualified researchers can request data. The Data Acquisition Committee (DAC) reviews the request, and then grants approval. Once biospecimens are in the biorepository, qualified researchers can request access to biosamples. The Parkinson's Disease Biosample Resource Acquisition Committee (PD BRAC) reviews the request and then grants approval.
Researchers find biomarkers that will significantly improve clinical trial design and outcomes for Parkinson's disease and related disorders.